Sinopharm
1099.HK
#2681
Rank
ยฃ4.98 B
Marketcap
ยฃ1.60
Share price
1.89%
Change (1 day)
-7.54%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: ยฃ1.83 Billion

According to Sinopharm's latest financial reports the company's current earnings are ยฃ82.21 Billion. In 2025 the company made an earning of ยฃ1.83 Billion, an increase over its 2024 earnings that were of ยฃ1.71 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025ยฃ1.83 B6.59%
2024ยฃ1.71 B-27.86%
2023ยฃ2.38 B-0.73%
2022ยฃ2.39 B-1.72%
2021ยฃ2.44 B11.7%
2020ยฃ2.18 B18.44%
2019ยฃ1.84 B10.85%
2018ยฃ1.66 B3.05%
2017ยฃ1.61 B36.48%
2016ยฃ1.18 B7.11%
2015ยฃ1.10 B12.38%
2014ยฃ0.98 B25.05%
2013ยฃ0.78 B22.54%
2012ยฃ0.64 B35.43%
2011ยฃ0.47 B52.24%
2010ยฃ0.31 B30.99%
2009ยฃ0.23 B60.59%
2008ยฃ0.14 B48.29%
2007ยฃ99.74 M123.29%
2006ยฃ44.67 M